Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | VCAM1 | P19320 | 6/20 | 0.46 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.43 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.43 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30946523 | 1.00 | TDP1 (0.59) | TDP1TSHRMAPK1ALDH1A1VCAM1 | |
| Acetone SCHEMBL27645515 | 0.90 | TDP1 (0.50) | TDP1TSHRMAPK1ALDH1A1VCAM1 | |
| Alcohol SCHEMBL27912165 | 0.89 | TDP1 (0.48) | TDP1TSHRMAPK1ALDH1A1VCAM1 | |
| SCHEMBL7514813 | 0.88 | ALDH1A1 (0.56) | TDP1TSHRMAPK1ALDH1A1VCAM1 | |
| SCHEMBL29702010 | 0.88 | ALDH1A1 (0.56) | TDP1TSHRMAPK1ALDH1A1VCAM1 | |
| SCHEMBL3302919 | 0.85 | TSHR (0.56) | TDP1TSHRMAPK1ALDH1A1GPR35 | |
| SCHEMBL2160036 | 0.84 | TDP1 (0.69) | TDP1TSHRMAPK1ALDH1A1VCAM1 | |
| SCHEMBL2145586 | 0.84 | TDP1 (0.69) | TDP1TSHRMAPK1ALDH1A1VCAM1 | |
| SCHEMBL29918148 | 0.84 | TDP1 (0.69) | TDP1TSHRMAPK1ALDH1A1VCAM1 | |
| Fluoride SCHEMBL10977459 | 0.83 | TDP1 (0.67) | TDP1TSHRMAPK1ALDH1A1VCAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 517 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240207381-A1 | BIHAPTENIZED AUTOLOGOUS VACCINES AND USES THEREOF | BIOVAXYS INC (US) | 2024-06-27 | — | — | US | claimed |
| CN-118179542-A | Carbon-based catalyst, and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-118084791-A | High-energy-density compound based on polynitrobenzene bipyrazole and synthesis method thereof | 南京理工大学 | 2024-05-28 | — | — | CN | claimed |
| CN-117986570-A | Wholly aromatic polyester amide resin and preparation method thereof | 中国科学院成都有机化学有限公司 | 2024-05-07 | — | — | CN | claimed |
| EP-4329779-A1 | BIHAPTENIZED AUTOLOGOUS VACCINES AND USES THEREOF | BioVaxys Inc. (US) | 2024-03-06 | — | — | EP | claimed |
| US-20230149534-A1 | HAPTENIZED CORONAVIRUS SPIKE PROTEINS | BIOVAXYS LLC | 2023-05-18 | — | — | US | claimed |
| WO-2023060220-A1 | METHODS OF IMMUNIZATION AGAINST CORONAVIRUS | BioVaxys Inc. (US) | 2023-04-13 | — | — | WO | claimed |
| CN-115916253-A | Haptenylated coronavirus spike protein | 拜奥维萨公司 | 2023-04-04 | — | — | CN | claimed |
| EP-4121103-A1 | HAPTENIZED CORONAVIRUS SPIKE PROTEINS | BioVaxys Inc. (US) | 2023-01-25 | — | — | EP | claimed |
| WO-2022232221-A1 | BIHAPTENIZED AUTOLOGOUS VACCINES AND USES THEREOF | BIOVAXYS, INC. (US) | 2022-11-03 | — | — | WO | claimed |
| EP-2368575-B1 | Dry formulation for transcutaneous immunization | INTERCELL USA INC (US) | 2014-10-01 | — | — | EP | claimed |
| CN-103304482-A | Multi-nitrobenzene substituted nitroimidazole energetic compound and preparation method thereof | UNIV NANJING SCIENCE & TECH | 2013-09-18 | — | — | CN | claimed |
| CN-100532377-C | Compound containing tetrazine polynitrobenzene and synthesis method thereof | BEIJING INST TECHNOLOGY (CN) | 2009-08-26 | — | — | CN | claimed |
| EP-1016405-A2 | Arylating medicaments | Radopath Pharmaceuticals International Limited (GB) | 2000-07-05 | — | — | EP | claimed |
| US-5635361-A | OBTAINING BLOOD SAMPLE, ASSAYING IN VITRO THE BINDING OF LEUKOCYTES OF SAMPLE WITH TUMOR MIMETIC CELL SURFACE ANTIGEN PRODUCED BY CHEMICAL TREATMENT OF HUMAN NORMAL CELLS WITH HALONITROBENZENES, CROSS-REACTS WITH TUMOR ANTIGENS | SAHASRABUDHE, VIKAS M. | 1997-06-03 | — | — | US | claimed |
| EP-0769309-A2 | Extinguishing chain for fighting fires | Dynamit Nobel GmbH Explosivstoff- und Systemtechnik (DE) | 1997-04-23 | — | — | EP | claimed |
| CN-1124012-A | Arylating medicaments | RADOPATH LTD (GB) | 1996-06-05 | — | — | CN | claimed |
| EP-0700287-A1 | ARYLATING MEDICAMENTS | RADOPATH LIMITED (GB) | 1996-03-13 | — | — | EP | claimed |
| WO-1994027584-A2 | ARYLATING MEDICAMENTS | RADOPATH LIMITED (GB) | 1994-12-08 | — | — | WO | claimed |
| EP-0493638-A1 | Novel composite explosives and method for making them | UNION ESPANOLA DE EXPLOSIVOS S.A. (ES) | 1992-07-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230149534-A1 | HAPTENIZED CORONAVIRUS SPIKE PROTEINS | ACE2, CD14, TMPRSS2 | TDP1 4545/4885TSHR 4289/4885MAPK1 3356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.